Unity Health Toronto
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 2017-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.unityhealth.to
Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma -2
Phase 2
- Conditions
- Chronic Subdural Hematoma
- Interventions
- Drug: Tranexamic Acid 500 MGDrug: Placebo
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2021-05-24
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 90
- Registration Number
- NCT04898712
- Locations
- 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood
Not Applicable
Completed
- Conditions
- HIV InfectionsHIV Testing
- Interventions
- Device: OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 600
- Registration Number
- NCT04810559
- Locations
- 🇨🇦
Women's Health in Women's Hands Community Health Centre, Toronto, Ontario, Canada
🇨🇦St. Michael's Hospital, Toronto, Ontario, Canada
🇨🇦Maple Leaf Research, Toronto, Ontario, Canada
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
Not Applicable
Recruiting
- Conditions
- Cardiac SurgeryDisorderPostoperativeHeart
- Interventions
- Other: Restrictive Transfusion StrategyOther: Liberal transfusion strategy
- First Posted Date
- 2021-02-15
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 1440
- Registration Number
- NCT04754022
- Locations
- 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸The Cooper Health System, Camden, New Jersey, United States
🇺🇸Columbia University, New York, New York, United States
Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER)
Not Applicable
Withdrawn
- Conditions
- Opioid UseOpioid-Related DisordersOpioid OverdoseEducationOpioid WithdrawalResusitation
- Interventions
- Other: SOONER Video & KitOther: Standard of Care
- First Posted Date
- 2021-02-05
- Last Posted Date
- 2022-10-03
- Lead Sponsor
- Unity Health Toronto
- Registration Number
- NCT04740099
- Locations
- 🇨🇦
St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada
Stellate Ganglion Block for Major Depressive Disorder.
Phase 4
Completed
- Conditions
- Treatment Resistant DepressionMajor Depressive Disorder
- Interventions
- Drug: Normal SalineDrug: Bupivacaine Hydrochloride
- First Posted Date
- 2021-01-27
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 10
- Registration Number
- NCT04727229
- Locations
- 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
Genetics Adviser: Evaluating a Digital Decision Support Tool for Genetic Results
Not Applicable
Completed
- Conditions
- Cancer
- Interventions
- Behavioral: Genetics ADvISER Decision Aid Plus Standard Genetic CounsellingBehavioral: Standard Genetic Counseling
- First Posted Date
- 2021-01-26
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 133
- Registration Number
- NCT04725565
- Locations
- 🇨🇦
Sunnybrook Hospital, Toronto, Ontario, Canada
🇨🇦Princess Margret Cancer Centre, Toronto, Ontario, Canada
🇨🇦Mount Sinai Hospital, Toronto, Ontario, Canada
STEP: Building Trauma Resilience Among Nurses and Personal Support Workers During and Beyond COVID-19
Not Applicable
Active, not recruiting
- Conditions
- Healthcare WorkersMental Health IssueTraumaStress
- Interventions
- Behavioral: Supportive Trauma Exposure Preparation Program
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 40
- Registration Number
- NCT04682561
- Locations
- 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study
Not Applicable
- Conditions
- Ischemia LimbAcute Lung InjuryAcute Respiratory Distress SyndromeCOVIDCorona Virus Infection
- Interventions
- Device: Remote Ischemic Conditioning
- First Posted Date
- 2020-12-09
- Last Posted Date
- 2020-12-09
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 30
- Registration Number
- NCT04659460
Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
Phase 2
Active, not recruiting
- Conditions
- Epistaxis NosebleedHereditary Hemorrhagic Telangiectasia
- Interventions
- First Posted Date
- 2020-11-27
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 30
- Registration Number
- NCT04646356
- Locations
- 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
Assessing the Impact of a Patient Education Platform to Augment the Informed Consent Process for Obstetrics and Gynecology Procedures
Not Applicable
- Conditions
- Hysteroscopy SurgeryInformed Consent
- Interventions
- Behavioral: Patient Education Platform
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 78
- Registration Number
- NCT04614688
© Copyright 2025. All Rights Reserved by MedPath